NCT02656095View on ClinicalTrials.gov

Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 1, 2018

Study Completion Date

March 1, 2018

Conditions
Lipoprotein Lipase Deficiency
Interventions
DRUG

Heparin

Participants will be given IV heparin in order to release lipoprotein lipase from capillary endothelial cells. Blood will be drawn 10-15 minutes post-heparin administration and run through assay to determine lipoprotein lipase levels.

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02656095 - Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment | Biotech Hunter | Biotech Hunter